Pharmaceutical giant Bristol-Myers Squibb (BMS) sued the federal government late Tuesday to establish a 340B rebate model, joining at least [...] …
Month: November 2024
Drugmaker contact pharmacy restrictions that apply to all covered entities have now outpaced those that only apply to hospitals, according [...] …
Provider groups have strongly denounced Sanofi’s new 340B rebate model for hospitals and health centers as a costly and harmful [...] …
More than a year after a key House panel passed legislation requiring 340B hospitals to report on a number of [...] …
Minnesota providers, namely the state’s largest 340B hospitals, generated hundreds of millions of dollars in collective net revenue from the [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
SPONSORED CONTENT
The Supreme Court recently upended a cornerstone of administrative law, known as “Chevron deference,” in Loper Bright Enterprises v. Raimondo. A major question for 340B stakeholders is how the Loper decision will impact the 340B program.
Although the Loper decision overturned 40 years
…
Three large hospital systems are asking a federal court to immediately block the government from removing them from the 340B [...] …
Breaking News
Wall Street Journal Reports Sanofi Will Become Third Drugmaker to Push for Controversial 340B Rebate
French pharmaceutical giant Sanofi reportedly plans to announce a 340B rebate model for hospitals today, making it the third drugmaker [...] …
News Alert
Proposition 34: Voters Narrowly Back Controversial California 340B ‘Revenge’ Ballot Measure
California voters have narrowly endorsed Proposition 34, a controversial Nov. 5 ballot measure that would require at least one major [...] …